J-Pharma Co., Ltd.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer (NCT07265674) | J-Pharma Co., Ltd. | 2026-05-11 |
| A Study of JPH034 in Healthy Adult Participants (NCT07534657) | J-Pharma Co., Ltd. | 2026-03-22 |
Track J-Pharma Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.